Salivary gland carcinomas. Part 1. Epidemiology, etiology, malignancy criteria, prognostic parameters and classification;Speicheldrüsenkarzinome. Teil I: Epidemiologie, ätiologie, malignitätskriterien, prognoseparameter und klassifikation

HNO

Volumn 53, Issue 9, 2005, Pages 817-828

  Lang, S ^a,d   Rotter, N ^a   Lorenzen, A ^b   Ihrler, S ^b   Eckel, R ^c   Holzel D ^c   Rasp, G ^b   Wollenberg, B ^a   Sommer, K ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c Tumorregister München ^*  (Germany)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Criteria of malignancy; Epidemiology; Prognostic variables; Risk factors; Salivary gland carcinomas

Indexed keywords

ACINAR CELL CARCINOMA; ADENOID CYSTIC CARCINOMA; ADENOSQUAMOUS CARCINOMA; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; DISEASE COURSE; FACIAL NERVE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; NECK DISSECTION; PLEOMORPHIC ADENOMA; PROGNOSIS; REVIEW; RISK FACTOR; SALIVARY GLAND CARCINOMA; TUMOR LOCALIZATION;

CARCINOMA; HUMANS; INCIDENCE; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SALIVARY GLAND NEOPLASMS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 25144455035     PISSN: 00176192     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00106-005-1293-3     Document Type: Review

References (14)

1. Armstrong JG, Harrison LB, Spiro RH, Fass DE, Strong EW, Fuks ZY (1990) Malignant tumors of major salivary gland origin. A matched-pair analysis of the role of combined surgery and postoperative radiotherapy. Arch Otolaryngol Head Neck Surg 116: 290-293
2. Billroth T (1859) Beobachtungen über Geschwülste der Speicheldrüsen. Virchow Arch Pathol Physiol 17: 357-375
3. Chilla R (1995) Diagnose und Therapie von Speicheldrüsentumoren, Teil I. HNO 43: 627-633
4. Chilla R (1995) Diagnose und Therapie von Speicheldrüsentumoren, Teil II. HNO 43: 681-694
5. Conley J, Hamaker RC (1975) Prognosis of malignant tumors of the parotid gland with facial paralysis. Arch Otolaryngol 101: 39-41
6. El-Naggar AK, Callender D, Coombes MM, Hurr K, Luna MA, Batsakis JG (2000) Molecular genetic alterations in carcinoma ex-pleomorphic adenoma: a putative progression model? Genes Chromosomes Cancer 27: 162-168
7. Frankenthaler RA, Luna MA, Lee SS et al. (1991) Prognostic variables in parotid gland cancer. Arch Otolaryngol Head Neck Surg 117: 1251-1256
8. Ihrler S, Blasenbreu-Vogt S, Sendelhofert A, Lang S, Zietz C, Lohrs U (2002) Differential diagnosis of salivary acinic cell carcinoma and adenocarcinoma (NOS). A comparison of (immuno-)histochemical markers. Pathol Res Pract 198: 777-783
9. Pedersen D, Overgaard J, Sogaard H, Elbrond O, Overgaard M (1992) Malignant parotid tumors in 110 consecutive patients: treatment results and prognosis. Laryngoscope 102: 1064-1069
10. Rice DH, Becker TS (1994) Clinical correlations in the head and neck. In: The salivary glands: radiology, pathology. Georg Thieme, New York, pp 37-54
11. Seifert G, Sobin LH (1991) Histological classification of salivary gland tumors. In: Organization WH (ed) International histological classification of tumours. Springer, Berlin Heidelberg New York Tokio
12. Spiro RH (1995) Changing trends in the management of salivary tumors. Semin Surg Oncol 11: 240-245
13. UICC (2002) TNM classification of malignant tumours. International Union Against Cancer. John Wiley & Sons,
14. Vander Poorten VL, Hart AA, van der Laan BF et al. (2003) Prognostic index for patients with parotid carcinoma: external validation using the nationwide 1985-1994 Dutch Head and Neck Oncology Cooperative Group database. Cancer 97: 1453-1463